Should I buy Lemonade stock after its share price crash?

Since mid-January, Lemonade stock has fallen from around $185 to $73 – a decline of about 60%. Edward Sheldon looks at whether this is a buying opportunity.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

One stock that has been caught up in the recent tech/growth sell-off is Lemonade Inc (NYSE: LMND). Since mid-January, shares in the fast-growing US insurance company have fallen from around $185 to $73 – a decline of about 60%. The stock is still well above its initial public offering (IPO) price of $29, however.

Is this share price weakness a buying opportunity for me? Let’s take a look at the investment case.

Lemonade: strong growth

Lemonade has grown at a strong rate in recent years, and the group’s first-quarter 2021 results, posted on 11 May, showed that the company continues to grow.

At the end of the first quarter, Lemonade had 1,096,618 customers on its books – a 50% increase on the number of customers (729,325) it had at the end of Q1 2020. That’s an impressive level of customer growth.

Meanwhile, the group reported a premium per customer of $229 for the quarter (Q1 2020: $183) and ‘in force premium’ (customers x premium per customer = in force premium) at the end of the period of $251.7m (Q1 2020: $133.3m).

The Q1 results weren’t all great, though. On the downside, the company generated a net loss of $49m. That was up from a net loss of £36.5m in Q1 2020. We have seen recently that the stocks of companies that are not yet profitable can be crushed in a sell-off. So, the fact that Lemonade is not yet profitable means it is a higher-risk stock.

Looking ahead, Lemonade clearly expects to keep growing. By the end of 2021, it is targeting in force premium of $376m to $382m along with revenue of $117m to $120m.

It’s worth noting that the company is shortly about to launch a new car insurance offering – ‘Lemonade Car.’ It believes that this will “dramatically increase” its total addressable market (car insurance in the US is a $300bn market). Its 2021 inforce premium guidance currently includes no material contribution from car insurance.

Overall, the progress the company is making is quite encouraging, in my view.

Lemonade stock: my concerns

I do have some concerns about Lemonade stock, however.

One is that short interest is currently very high. According to data provider 2iQ Research, short interest at Lemonade is about 22% at present. This means that short sellers (sophisticated investors who are betting against the stock) are aggressively targeting LMND stock.

Another concern is a recently published open letter to CEO Dan Schreiber from short seller Muddy Waters. In the letter, Muddy Waters states that it discovered a security flaw on Lemonade’s website that potentially exposes its customers’ personal identifiable information (PII). The short selling firm states that Lemonade’s failures possibly implicate costly legal and regulatory breaches.

Finally, the valuation still looks steep even after the recent share price fall. Currently, LMND has a market capitalisation of $4.5bn. This means its forward-looking price-to-sales ratio is about 38. That seems a bit high, to my mind.

LMND stock: my move now

Weighing everything up, I see Lemonade stock as too risky for my portfolio right now. The company is growing quickly. However, its losses, its short interest, and its valuation concern me.

All things considered, I think there are better growth stocks I could buy.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended Lemonade, Inc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

With an £8K lump sum, I could create an annual second income worth £5,347

This Fool explains how a second income is achievable by using a lump sum, investing in stocks, and the magic…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BT share price in the next 3 years

With the BT share price down so low, the dividend looks very nice indeed. The company's debt is off-putting, though.…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

28% revenue growth per year and down over 20% in price! Should I invest in this niche FTSE 250 company?

Oliver says this FTSE 250 company has done an excellent job bringing auctioning into the modern world. Will he invest…

Read more »

Investing Articles

After gaining over 200% in 12 months, what’s next for Nvidia stock?

Oliver thinks Nvidia stock could be as enduring an investment as Amazon. Even given the valuation risks, he says he…

Read more »